Adherence to Immunoprophylaxis Regimens for Respiratory Syncytial Virus Infection in Insured and Medicaid Populations. - Wikidata - awgldk - TriplyDB

Adherence to Immunoprophylaxis Regimens for Respiratory Syncytial Virus Infection in Insured and Medicaid Populations.

Adherence to Immunoprophylaxis Regimens for Respiratory Syncytial Virus Infection in Insured and Medicaid Populations.

http://www.wikidata.org/entity/Q33705088

about

Evaluation of recent New Vaccine Surveillance Network data regarding respiratory syncytial virus hospitalization rates in US preterm infants Relative Importance and Additive Effects of Maternal and Infant Risk Factors on Childhood Asthma.Effectiveness of Palivizumab in High-risk Infants and Children: A Propensity Score Weighted Regression Analysis.α-Asarone suppresses the proliferation and migration of ASMCs through targeting the lncRNA-PVT1/miR-203a/E2F3 signal pathway in RSV-infected rats.Respiratory syncytial virus immunoprophylaxis in high-risk infants and development of childhood asthma.Effectiveness of Respiratory Syncytial Virus Immunoprophylaxis on Bronchiolitis Hospitalizations among High-risk Infants.Adherence and outcomes: a systematic review of palivizumab utilization.

P2860

Q31047460-17FA22DD-3D36-4982-8CD4-3ADEE5D3D5D0 Q35966011-F2E4E124-882B-43C7-81E2-5403773072C2 Q40122511-11D4F36D-A44C-45D6-B2DD-75B01BA85A99 Q40199397-56CAFEFB-A624-4E51-8EC0-D2EB1F35D32B Q40664195-0662429D-880C-4FBD-8F83-8AF31363EB64 Q47551236-232EC370-0435-4775-870E-B483118142D6 Q47582466-9C7F9952-3D72-4859-9858-D313F144CA2C

P2860

Adherence to Immunoprophylaxis Regimens for Respiratory Syncytial Virus Infection in Insured and Medicaid Populations.

http://www.wikidata.org/entity/Q33705088

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Adherence to Immunoprophylaxis ...... ured and Medicaid Populations.

@ast

Adherence to Immunoprophylaxis ...... ured and Medicaid Populations.

@en

type

label

Adherence to Immunoprophylaxis ...... ured and Medicaid Populations.

@ast

Adherence to Immunoprophylaxis ...... ured and Medicaid Populations.

@en

prefLabel

Adherence to Immunoprophylaxis ...... ured and Medicaid Populations.

@ast

Adherence to Immunoprophylaxis ...... ured and Medicaid Populations.

@en

P1433

Q33705088-D408C5B0-9D33-4B05-AF26-C8C4F10F2AD2

P1476

Q33705088-B2FDA4FA-194E-4831-A6FB-576F200D2289

P2093

Q33705088-0664EB6F-ACB0-4847-8703-CDAB49D3DEDA

Q33705088-22FEDA3F-DAEE-4806-B363-F12BD697ADBD

Q33705088-2664A82F-31E0-4D4E-8639-8BB8B0CD7B42

Q33705088-2675D803-8312-4ABE-83CC-E183B0EE5737

Q33705088-3713FC18-7898-498E-A949-FF226628749C

Q33705088-52BCBCAB-416F-4D83-81B5-D56ED88A9FD0

Q33705088-708204AD-233A-4D2D-AFAA-4563E39C4BC3

P2860

Q33705088-04E7117E-08A1-45CA-9C4B-A64DA6F59C22

Q33705088-22A1C00E-C0B7-46A2-931E-6862206B4ED2

Q33705088-244ECF2C-BB48-4F97-8D2D-39930EBC3057

Q33705088-2DFEDB3C-18CE-47DA-BDE6-25F735ABC2B1

Q33705088-30E424E6-B6FB-4B74-9008-37CDF7CE2751

Q33705088-36BEDA30-D390-48F8-AFBB-69C71C934D22

Q33705088-41BA6786-DD46-4B26-B4D6-D730AB339958

Q33705088-44E90D14-4D67-42F6-B8DE-06FBE85CEF68

Q33705088-45DFAFAA-0841-46D8-AF05-0D13AED9E4FB

Q33705088-49B92185-B5D3-49ED-B5CD-539EE400E4E5

P304

Q33705088-AA6327A3-AE8E-4BF2-8A01-CB6BEBB839CA

P31

Q33705088-CEDE9655-78C7-40A0-8E8E-F00AD8635DB4

P356

Q33705088-019E1223-CE3E-4F0D-A2AB-6426D30D89C8

P433

Q33705088-7EA36B58-25BC-47F9-948B-7444D81F6BB8

P478

Q33705088-D188D29D-BB20-4C67-B562-428ADEEDD7BE

P50

Q33705088-0BE2FCBB-A7B5-447F-A81B-CCA0BD6879F5

Q33705088-B9659100-1419-4AF0-95CE-BECD12EBA844

P577

Q33705088-11CA5E9F-0C30-4B27-844B-45D8F70909CD

P5875

Q33705088-9BAD43CD-C192-46CE-A788-0109671B9EF9

P698

Q33705088-C99B225D-03E0-4E4F-9D9E-6E40C6545BC6

P932

Q33705088-7CFB3478-4462-464E-84E4-28BF57BA3412

P356

P1433

Journal of the Pediatric Infectious Diseases Society

P1476

Adherence to Immunoprophylaxis ...... ured and Medicaid Populations.

@en

P2093

Chantel Sloan

http://www.w3.org/2001/XMLSchema#string

Ed Mitchel

http://www.w3.org/2001/XMLSchema#string

Eileen M Walsh

http://www.w3.org/2001/XMLSchema#string

Gabriel J Escobar

http://www.w3.org/2001/XMLSchema#string

Pingsheng Wu

http://www.w3.org/2001/XMLSchema#string

Sherian Xu Li

http://www.w3.org/2001/XMLSchema#string

Tina Hartert

http://www.w3.org/2001/XMLSchema#string

P2860

Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children

Evidence of a causal role of winter virus infection during infancy in early childhood asthma

Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections

Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections

Rapid retrieval of neonatal outcomes data: the Kaiser Permanente Neonatal Minimum Data Set.

Use of Medicaid data for pharmacoepidemiology.

Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season. The Palivizumab Outcomes Study Group.

Risk of primary infection and reinfection with respiratory syncytial virus.

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.

P304

205-214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JPIDS/PIT007

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Tebeb Gebretsadik

Kecia N. Carroll

P577

2013-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263095902

http://www.w3.org/2001/XMLSchema#string

P698

24921044

http://www.w3.org/2001/XMLSchema#string

P932

4043196

http://www.w3.org/2001/XMLSchema#string